Breed's Hill Capital’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
BTW
Breed's Hill Capital's ACLS Position: Q2 2025 in Review
Breed's Hill Capital opened a new position in Axcelis (ACLS) in Q2 2025: 3,000 shares worth $209K. The stake represents 0.1% of the portfolio and ranks #132 among its holdings. This is a return to the name: Breed's Hill Capital previously reported a position in ACLS as recently as Q4 2024.
Breed's Hill Capital first reported a position in ACLS in Q4 2024 and has held it in 2 quarters since. The position peaked at $210K in Q4 2024. 328 funds tracked by Wall St. Rank hold ACLS as of Q2 2025.
- Breed's Hill Capital held 3,000 shares of Axcelis worth $209K as of Q2 2025.
- Axcelis was a new Breed's Hill Capital position in Q2 2025.
- Axcelis made up 0.1% of Breed's Hill Capital's portfolio in Q2 2025, its #132 holding.
- Breed's Hill Capital first reported a position in Axcelis in Q4 2024 and has held it in 2 quarters since.
- Breed's Hill Capital's Axcelis position peaked at $210K in Q4 2024.
- 328 funds tracked by Wall St. Rank held Axcelis as of Q2 2025.
Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.